# US 2026/0098293 A1 · Ssb method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0098293 A1
- Document ID: US20260098293A1
- Status: Published application
- Kind: A1
- Application number: 19/267,814
- Filed: 2025-07-14
- Published: 2026-04-09
- Earliest claimed: 2012-07-19
- Assignees: Oxford Nanopore Technologies PLC
- Applicants: Oxford Nanopore Technologies PLC
- Inventors: James White; Ruth Moysey; Mihaela Misca
- Web page: https://patentgrep.com/patent/US20260098293A1

## CPC

- C12Q 1/6869: Methods for sequencing
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The invention relates to a method of characterising a target polynucleotide using a single-stranded binding protein (SSB). The SSB is either an SSB comprising a carboxy-terminal (C-terminal) region which does not have a net negative charge or a modified SSB comprising one or more modifications in its C-terminal region which decreases the net negative charge of the C-terminal region.

## Claims

### Claim at position 1

-38. (canceled)

### Claim 39

A method of unblocking a transmembrane protein pore, the method comprising:
(i) contacting the transmembrane protein pore with a polypeptide under an applied electrical potential;
(ii) measuring a current through the transmembrane protein pore indicative of blocking of the transmembrane protein pore by the polypeptide; and
(iii) reversing the applied electrical potential to clear the polypeptide from the transmembrane protein pore, thereby unblocking the transmembrane protein pore.

### Claim 40 (depends on 39)

The method of claim 39, wherein the polypeptide comprises a charged tail that contacts the transmembrane protein pore.

### Claim 41 (depends on 39)

The method of claim 39, wherein the polypeptide is a protein.

### Claim 42 (depends on 41)

The method of claim 41, wherein the protein is a single-stranded binding protein (SSB).

### Claim 43 (depends on 39)

The method of claim 39, wherein measuring a current through the transmembrane protein pore comprises measuring an ion current.

### Claim 44 (depends on 39)

The method of claim 39, wherein the applied electrical potential is a voltage potential.

### Claim 45 (depends on 44)

The method of claim 44, wherein the voltage potential is in the range of −400 mV to +400 mV.

### Claim 46 (depends on 39)

The method of claim 39, wherein reversing the applied electrical potential comprises applying a cycle of a period of a positive holding potential followed by a period of a negative holding potential.

### Claim 47 (depends on 46)

The method of claim 46, wherein the negative holding potential is followed by a rest period where no potential is applied.

### Claim 48 (depends on 39)

The method of claim 39, wherein the transmembrane protein pore is provided in an array of individually addressable transmembrane protein pores.

### Claim 49 (depends on 39)

The method of claim 39, wherein the transmembrane protein pore is selected from hemolysin, leukocidin, Mycobacterium smegmatis porin A (MspA), MspB, MspC, MspD, outer membrane phospholipase A, Neisseria autotransporter lipoprotein (NaIP) and WZA.

### Claim 50 (depends on 39)

The method of claim 39, wherein the barrel or channel of the transmembrane protein pore has a diameter of less than 7 nm at its narrowest point.
